IL-10 as a mediator in the HPA axis and brain

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 140-148

  Smith, Eric M ^a,b   Cadet, Patrick ^c   Stefano, George B ^c   Opp, Mark R ^a   Hughes Jr , Thomas K ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cytokines; Lymphocytes; Neuroendocrine hormones; Neuroimmunomodulation; Pituitary

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GLUCOCORTICOID; INTERLEUKIN 1; INTERLEUKIN 10; TUMOR NECROSIS FACTOR;

AUTOREGULATION; CYTOKINE PRODUCTION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; LYMPHOCYTE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033378618     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00206-4     Document Type: Article

References (72)

1. Balasingam V., Yong V.W. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16:1996;2945-2955.
2. Bancherau J., de Paoli P., Valle A., Garcia E., Rousett F. Long-term human B-cell lines dependent on interleukin-4 and antibody to CD40. Science. 251:1991;70-72.
3. Bernardini R., Kamilaris T.C., Calogero A.E., Johnson E.O., Gomez M.T., Gold P.W., Chrousos G.P. Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat. Endocrinology. 126:1990;2876-2881.
4. Bhardwaj R.S., Schwarz A., Becher E., Mahnke K., Aragane Y., Schwarz T., Luger T.A. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J. Immunol. 156:1996;2517-2521.
5. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by IL-10. J. Exp. Med. 174:1991;1549-1555.
6. Bucala R. MIF re-discovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. Cytokine Growth Factor Rev. 7:1996;19-24.
7. Burdin N., Peronne C., Banchereau J., Rousset F. Epstein-Barr virus transformation induces B-lymphocytes to produce interleukin-10. J. Exp. Med. 177:1993;295-304.
8. Cannella B., Gao Y.L., Brosnan C., Raine C.S. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;735-746.
9. Chabot S., Williams G., Hamilton M., Sutherland G., Yong V.W. Mechanisms of IL-10 production in human microglia-T cell interaction. J. Immunol. 162:1999;6819-6828.
10. Chen W.F., Zlotnik A. A novel cytotoxic T-cell differentiation factor. J. Immunol. 147:1990;528-534.
11. Chernoff A.E., Granowitz E.V., Shapiro L., Vannier E.X.L.G., Angel J.B., Kennedy J.S., Rabson A.R., Wolff S.M., Dinarello C.A. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154:1995;5492-5499.
12. Clerici M., Shearer G.M. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
13. Crucian B., Dunne P., Friedman H., Ragsdale R., Pross S., Widen R. Detection of altered T helper 1 and T helper 2 cytokine production by peripheral blood mononuclear cells in patients with multiple sclerosis utilizing intracellular cytokine detection by flow cytometry and surface marker analysis. Clin. Diagn. Lab. Immunol. 3:1996;411-416.
14. de Vries J.E. Immunosuppressive and anti-inflammatory properties of IL-10. Ann. Med. 27:1995;537-541.
15. de Waal Malefyt R., Abrams J., Bennett B., Figdor C., de Vries J.E. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
16. Defrance T., Vanbervliet B., Briere F., Durand I., Rousett F., Bancherau J. Interleukin-10 and TGF beta cooperate to induce anti-CD40 activated naive human B-cells to secrete immunoglobulin A. J. Exp. Med. 175:1992;671-682.
17. Fiorentino D.F., Bond M.A., Mosmann T.R. Two types of mouse helper T-cells IV, Th2 clones secrete a factor that inhibits cytokine production by Th1 cells. J. Exp. Med. 170:1989;2081-2095.
18. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
19. Gallo P., Sivieri S., Rinaldi L., Yan X.B., Loiil F., De Rossi A., Tavolato B. Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J. Neurolog. Sci. 126:1994;49-53.
20. Gelati M., Lamperti E., Dufour A., Corsini E., Venegoni E., Milanese C., Nespolo A., Salmaggi A. IL-10 production in multiple sclerosis patients, SLE patients and healthy controls: preliminary findings. Ital. J. Neurol. Sci. 18:1997;191-194.
21. Go N.F., Castle B.E., Barrett R., Kastlestein R., Dang W., Mosmann T.R., Moore K.W., Howard M. Interleukin-10 (IL-10) A novel B-stimulatory factor: unresponsiveness of X-chromosome linked immunodeficient B-cells. J. Exp. Med. 172:1990;1625-1631.
22. Hishii M., Nitta T., Ishida H., Ebato M., Kurosu A., Yagita H., Sato K., Okumura K. Human glioma derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery. 37:1995;1160-1167.
23. Ho A.S., Moore K.W. Interleukin-10 and its receptor. Ther. Immunol. 1:1994;173-185.
24. Holland G., Zlotnik A. Interleukin-10 and cancer. Cancer Invest. 11:1993;751-758.
25. Howard M., O'Garra A., Ishida H., de Waal Malefyt R., de Vries J. Biological properties of IL-10. J. Clin. Immunol. 12:1992;239-247.
26. Huettner C., Paulus W., Roggendorf W. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am. J. Pathol. 146:1995;317-322.
27. Hughes, T.K., Chin, R., 1994. Interactions of neuropeptides and lymphokines. In: Scharrer, B., Smith, E.M., Stefano, G.B. (Eds.), Neuropeptides and Immunoregulation. Springer, Berlin, p. 100.
28. Hughes T.K., Cadet P., Rady P.L., Tyring S.K., Chin R., Smith E.M. Evidence for the production and action of interleukin-10 in pituitary cells. Cell Mol. Neurobiol. 14:1994;59-69.
29. Issazadeh S., Ljungdahl A., Hojeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J. Neuroimmunol. 61:1995;205-212.
30. Jander S., Pohl J., D'Urso D., Gillen C., Stoll G. Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am. J. Pathol. 152:1998;975-982.
31. Johnson H.M., Smith E.M., Torres B.A., Blalock J.E. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. U.S.A. 79:1982;4171-4174.
32. Johnson H.M., Torres B.A., Smith E.M., Dion L.D., Blalock J.E. Regulation of lymphokine (gamma-interferon) production by corticotropin. J. Immunol. 132:1984;246-250.
33. Jones, B.E., 1989. Basic mechanisms of sleep-wake states. In: Kryger, M.H., Roth, T., Dement, W.C. (Eds.), Principles and Practice of Sleep Medicine. W.B. Saunders, Philadelphia, p. 121.
34. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
35. MacNeil I.A., Suda T., Moore K.W., Mosmann T.R., Zlotnik A. IL-10: a novel growth cofactor for mature and immature T-cells. J. Immunol. 145:1990;4167-4175.
36. Martinez C., Delgado M., Gomariz R.P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:1996;4128-4136.
37. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
38. Monteyne P., Van L.V., Marichal R., Sindic C.J. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation. J. Neuroimmunol. 80:1997;137-142.
39. Mosmann T.R. Properties and functions of interleukin-10. Adv. Immunol. 56:1994;1-26.
40. Musette P., Benveniste O., Lim A., Bequet D., Kourilsky P., Dormont D., Gachelin G. The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis. Res. Immunol. 147:1996;435-441.
41. Nitta T., Hishii M., Sato K., Okumura K. Selective expression of interleukin-10 gene within glioblastoma multiforme. Brain Res. Dev. Brain Res. 649:1994;122-128.
42. Oates E.L., Allaway G.P., Armstrong G.R., Boyajian R.A., Kehrl J.H., Prabhakar B.S. Human lymphocytes produce pro-opiomelanocortin gene-related transcripts. Effects of lymphotropic viruses. J. Biol. Chem. 263:1988;10041-10044.
43. Opp M.R., Krueger J.M. Anti-interleukin-1 beta reduces sleep and sleep rebound after sleep deprivation in rats. Am. J. Physiol. 266:1994;R688-95.
44. Opp M.R., Smith E.M., Hughes T.K. Jr. Interleukin-10 (cytokine synthesis inhibitory factor) acts in the central nervous system of rats to reduce sleep. J. Neuroimmunol. 60:1995;165-168.
45. Opp M.R., Rady P.L., Hughes T.K.J., Cadet P., Tyring S.K., Smith E.M. Human immunodeficiency virus envelope glycoprotein 120 alters sleep and induces cytokine mRNA expression in rats. Am. J. Physiol. 270:1996;R963-R970.
46. Rady P.L., Smith E.M., Cadet P., Opp M.R., Tyring S.K., Hughes T.K. Jr. Presence of interleukin-10 transcripts in human pituitary and hypothalamus. Cell Mol. Neurobiol. 15:1995;289-296.
47. Ramierz F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 156:1996;2406-2412.
48. Rousset F., Garcia E., DeFrance T.E., Peronne C., Vezzio N., Hsu D., Kastelein R., Moore K.W., Bancherau J. Interleukin-10 is a potent growth and differentiation factor for activated human B-lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 89:1992;1890-1893.
49. Rudick R.A., Ransohoff R.M., Peppler R., VanderBrug M.S., Lehmann P., Alam J. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann. Neurol. 40:1996;618-627.
50. Salmaggi A., Dufour A., Eoli M., Corsini E., La Mantia L., Massa G., Nespolo Milanese C. Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J. Neurol. 243:1996;13-17.
51. Sheng W.S., Hu S., Kravitz F.H., Peterson P.K., Chao C.C. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro. Clin. Diagn. Lab. Immunol. 2:1995;604-608.
52. Sher A., Fiorentino D., Caspar P., Pearce E., Mosmann T.R. Production of IL-10 by CD4. T lymphocytes correlates with downregulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147:1992;2713-2716.
53. Smith E.M. Hormonal activities of cytokines. Chem. Immunol. 69:1997;185-202.
54. Smith E.M., Galin F.S., LeBoeuf R.D., Coppenhaver D.H., Harbour D.V., Blalock J.E. Nucleotide and amino acid sequence of lymphocyte-derived corticotropin: endotoxin induction of a truncated peptide. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1057-1060.
55. Stefano G.B., Rodriguez M., Glass R., Cesares F., Hughes T.K., Bilfinger T.V. Hyperstimulation of leukocytes by plasma from cardiopulmonary by-pass patients is diminished by morphine and IL-10 pretreatment. J. Cardiovasc. Surg. 36:1995;25-30.
56. Stefano G.B., Prevot V., Beauvillain J.C., Hughes T.K. Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production. Neurosci. Lett. 256:1998;167-170.
57. Stuart A.D., Stewart J.P., Arrand J.R., Macket M. The Epstein-Barr virus encoded viral interleukin-10 enhances transformation of human B-lymphocytes. Oncogene. 11:1995;1711-1719.
58. Suda T., O'Garra A., MacNeil I., Fischer M., Bond M., Zlotnik A. Identification of a novel thymocyte growth promoting factor derived from B-cell lymphomas. Cell. Immunol. 129:1990;228-240.
59. Suzuki T., Tahara H., Narula S., Moore K.W., Robbins P.D., Lotze M.T. Viral interleukin-10 (IL-10), the human herpes virus 4 cellular homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:1995;477-486.
60. Tabardel Y., Duchateau J., Schmartz D., Marecaux G., Shahla M., Barvais L.X.L.J., Vincent J.L. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery. 119:1996;76-80.
61. Thompson-Snipes L., Dhar V., Bond M.W., Mosmann T.R., Moore K.W., Rennick D. Interleukin-10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173:1991;507-510.
62. van der Poll T., Coyle S.M., Barbosa K., Braxton C.C., Lowry S.F. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J. Clin. Invest. 97:1996;713-719.
63. van der Poll T., Barber A.E., Coyle S.M., Lowry S.F. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J. Clin. Endocrinol. Metab. 81:1996;3604-3606.
64. Vankelecom H., Carmeliet P., Heremans H., Van Damme J.X.D.R., Billiau A., Denef C. Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology. 126:1990;2919-2926.
65. Vieira P., Waal-Malefyt R., Dang M.-N., Johnson K.E., Kastelein R., Fiorentino D.F., deVries J.E., Roncarolo M.-G., Mosmann T.R., Moore K.W. Isolation and expression of human cytokine synthesis inhibitory factor: Homology to Epstein-Barr open reading frame BCRF1. Proc. Natl. Acad. Sci. U.S.A. 88:1991;1172-1176.
66. Wagner S., Czub S., Greif M., Vince G.H., Suss N., Kerkau S., Rieckmann P., Roggendorf W., Roosen K., Tonn J.C. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int. J. Cancer. 82:1999;12-16.
67. Wang F., Sengupta T.K., Zhong Z., Ivashkiv L.B. Regulation of the balance of cytokine production and the signal transducer and activator of transcription. J. Exp. Med. 182:1995;1825-1831.
68. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:1995;9558-9563.
69. Webster E.L., Elenkov I.J., Chrousos G.P. The role of corticotropin-releasing hormone in neuroendocrine-immune interactions. Mol. Psychiatry. 2:1997;368-372.
70. Woloski B.M., Smith E.M., Meyer W.J.3., Fuller G.M., Blalock J.E. Corticotropin-releasing activity of monokines. Science. 230:1985;1035-1037.
71. Wong M.L., Bongiorno P.B., Rettori V., McCann S.M., Licinio J. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. Proc. Natl. Acad. Sci. U.S.A. 94:1997;227-232.
72. Zlotnik A., Moore K.W. Interleukin 10. Cytokine. 3:1991;336-336.